The European Society for Medical Oncology (ESMO) is pleased to announce the publication of the latest version of the scale that measures the clinical benefit of cancer treatments, the ESMO-MCBS ...

Armata Pharmaceuticals ARMP shares have skyrocketed 72.3% in the past month. The massive surge in the stock price was ...

AML patients achieve remission with mipletamig + standard of care across two trialsMipletamig triplet combination continues to outperform standard doublet benchmarkNo cytokine release ...

Corporate R&D event highlighted positive ACR-368 data in endometrial cancer patients who had all received prior anti-PD-1 and platinum-based chemotherapy Confirmed overall response rate (cORR) of 35% ...

Statement from Woo Jong Lee, CEO of Connext "By confirming both safety and efficacy in the dose escalation part of Phase 1/2 study, CNT201 offers a new non-surgical treatment option for patients ...

"We are excited about the potential of BDC-3042 to help patients with cancer. This initial dose-escalation study demonstrated a favorable safety profile, dose-dependent biologic activity, and ...

“We are excited about the potential of BDC-3042 to help patients with cancer. This initial dose-escalation study demonstrated a favorable safety profile, dose-dependent biologic ...

Following a review of safety and efficacy data, the Safety Review Committee (SRC) has approved dose-escalation to the next, higher planned dose in Cohort 2. “This milestone marks an important ...

Heterogeneous escalation of radiotherapy dose guided by imaging in locally advanced non–small cell lung cancer (NSCLC) does not increase early toxicity, a new trial found. “Patients with ...

Dosage chart for weight loss and management ... A starting dose and a dose escalation schedule for Wegovy are recommended to help lower the risk of certain side effects. Specifically, slowly ...